MARTHA E. MANNING - 24 May 2022 Form 4 Insider Report for MARINUS PHARMACEUTICALS, INC.

Role
VP Gen Counsel and Corp Sec.
Signature
/s/ Debra A. Mohollen, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 May 2022
Net transactions value
$0
Form type
4
Filing time
26 May 2022, 16:39:57 UTC
Previous filing
07 Feb 2022
Next filing
30 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNS Common Stock Award $0 +5,790 +45% $0.000000 18,657 24 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units (RSUs). The RSUs vest in two equal installments, with the first installment vesting on August 4, 2023, and the second installment vesting on August 4, 2024, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.